UCB - نسبة السعر إلى الأرباح





Pe تغيير تاريخ
Alcon AG 36.42 1.77 2026-03
Almirall 79.43 0.3 2025-12
Amarin 91.05 88.3 2023-06
argenx SE 35.53 3.41 2026-06
AstraZeneca 29.59 2.3 2026-03
Bayer 3.4 8.75 2026-03
Genmab 17.14 4.39 2025-12
GlaxoSmithKline 14.87 3.72 2026-03
GRIFOLS 10.98 5.83 2026-03
Hikma Pharmaceutical 10.43 3.72 2025-12
Lakefront Biotherapeutics 2.54 0.6 2026-03
Lonza 34.34 2.58 2025-12
Merck 12.74 7.82 2026-03
Novartis 20.17 2.32 2026-03
Orion 17.23 1.3 2026-06
Recordati 17.66 7.44 2026-03
Roche Holding 16.09 3.51 2025-12
Sanofi 11.84 0.14 2026-03
UCB 29.7 5.52 2025-12
Unibail Rodamco 10.36 0.43 2025-12